EMFAT
HTGM

Emerald Mutual Fund Advisers Trust’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-694
Closed -$1.39M – 288
2015
Q2 		$1.39M Buy
+694
New +$1.77M 0.11% 155

Other funds holding HTGM

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's HTGM Position: Q3 2015 in Review

Emerald Mutual Fund Advisers Trust sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q3 2015, closing a stake of 694 shares — an estimated $1.39M sold.

Emerald Mutual Fund Advisers Trust first reported a position in HTGM in Q2 2015 and held it in 1 quarter. The position peaked at $1.39M in Q2 2015. 21 funds tracked by Wall St. Rank hold HTGM as of Q3 2015.

  • Emerald Mutual Fund Advisers Trust reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 694 HTG Molecular Diagnostics, Inc. Common Stock shares in Q3 2015, an estimated $1.39M.
  • Emerald Mutual Fund Advisers Trust first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q2 2015 and held it in 1 quarter.
  • Emerald Mutual Fund Advisers Trust's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $1.39M in Q2 2015.
  • 21 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q3 2015.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q3 2015, filed 23 Oct 2015.